Dancey, Janet Ellen
- Queen's University at Kingston (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,362
- Sustained Excellence
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.5M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,362
By linked amount among FY2023 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Dancey, Janet Ellen as a PI. Multi-PI records show the full award amount for context.
- 5U10CA180863-10U10Contact PICanadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network$3.5Maward amount
- 3U10CA180863-09S1U10Contact PICanadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network$25.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Dancey, Janet Ellen as a PI.
FY2023 award administered by Queen's University at Kingston ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardQueen's University at Kingston
- 2014$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #1277
- 2014Entered Top 25% NationallyRanked #1277
- 2014Entered Top 10% NationallyRanked #1277
- 2015$5M Cumulative Funding
- 2017$10M Cumulative Funding
- 2020Entered Top 5% NationallyRanked #618
- 2022$25M Cumulative Funding